Nephrologist
Paraskevi Pavlakou
Patients with kidney disease need early diagnosis of a disease that in many cases is asymptomatic. A meaningful doctor-patient relationship is crucial both for slowing down the progression of the disease and for the optimal management of those who need replacement of their renal function. The main objective is to safeguard renal health.
My place of origin is Krokees in Laconia. I completed my studies at the Medical School of the University of Patras. I specialized in Nephrology at the Nephrology Department of the University Hospital of Ioannina. I worked as a Nephrologist for 3 years at the Nephrology Department of the University Hospital of Patras.
- 2003-2009: Medical School of the University of Patras, Medical Degree (2009)
- 04/2013-11/2014: Specialization in General Pathology, General Hospital of Patras
- 01/2015-08/2019: Specialization in Nephrology, General Hospital of Ioannina, Greece
- 08/2019-08/2022: Assistant Consultant Nephrology, Nephrology Department, General Hospital of Patras, Greece
- European Renal Association – European Dialysis and Transplantation Association (ERA – EDTA) [11/2015 – current]
- International Society of Nephrology (ISN), [11/2015 – 01/2019]
- Greek Nephrological Society [11/2015 – current]
- “Diabetic nephropathy” in a non-diabetic patient”, Pathology – Research and Practice Journal (2016)
- ‘PCSK9 in chronic kidney disease’, Int Urol Nephrol (2017)
- ‘Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms—Biomarkers—Interventions, and Future Perspectives’, Oxid Med Cell Longev., (2017)
- ‘Oxidative Stress and the Kidney in the Space Environment’, Int J Mol Scien, (2018)
- ‘Hypertension In Chronic Kidney Disease: Novel Insights’, Curr Hypertens Rev, (2019)
- ‘Histological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patients’, Histopathology journal (2019)
- ‘Case Report: Kidney transplantation in a patent with acquired agammaglobulinemia and SLE. Issues and challenges’, Frontriers in Medicine, (2021)
- ‘Association between PCSK9 levels and markers of inflammation, oxidative stress and endothelial dysfunction in a population of nondialysis chronic kidney disease patients’, Oxidative Medicine and Cellular Longevity, (2021)
- ‘Survival of peritoneal membrane function on biocompatible dialysis solutions in a peritoneal dialysis cohort assessed by a novel test’, Journal of Clinical Medicine (2021)
- ‘PCSK9 levels and markers of inflammation, oxidative stress and endothelial dysfunction in a population of non-dialysis chronic kidney disease patients: Is there an association?’, Atherosclerosis (2021)
